Skip to main content

Table 1 Selected covariates of patients treated with laparoscopic or transanal total mesorectal excision for rectal cancer, with standardised differences before and after inverse probability of treatment weighting

From: Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis

Variable

Surgical approach

Standardised differences

TaTME, No. (%)

LapTME, No. (%)

Before IPTW

After IPTW

Total, No.

344

366

  

Center

Barcelona

194 (56.4)

212 (57.9)

0.1189

0.1238

Gelderse Vallei

90 (26.1)

79 (21.5)

AMC

60 (17.4)

75 (20.4)

Age, years (mean, 95% CI)

66.5 (65.2–67.7)

66.4 (65.2–67.6)

0.0071

< 0.0001

Gender

Female

104 (30.2)

137 (37.4)

0.1526

−0.007

Male

240 (69.7)

229 (62.5)

ASA

I

44 (12.7)

68 (18.5)

0.0682

0.0002

II

239 (69.4)

227 (62.0)

III

61 (17.7)

71 (19.4)

BMI, kg/m2(mean, 95% CI)

25.5 (25.1–25.9)

26.4 (25.7–27.0)

−0.161

−0.017

Distance from AV, cm (mean, 95% CI)

7.2 (6.9–7.5)

6.5 (6.1–6.8)

0.2487

0.0024

Clinical T-stage

cT1

0 (0.0)

4 (1.1)

0.0726

0.0047

cT2

27 (7.8)

41 (11.8)

cT3

289 (84.0)

266 (76.6)

cT4

28 (8.1)

35 (10.0)

Clinical N-stage

cN0

148 (43.0)

113 (30.8)

−0.288

0.0005

cN1

155 (45.0)

181 (49.4)

cN2

41 (11.9)

72 (19.6)

Baseline threatened/involved CRM

94 (27.3)

101 (27.6)

−0.006

−0.009

Pathologic response to NATa

TRG 1

93 (38.2)

103 (36.5)

−0.144

−0.003

TRG 2

76 (31.2)

85 (30.1)

TRG 3

74 (30.4)

94 (33.3)

Pathological T-stage

  

−0.144

−0.003

pT0

40 (11.6)

35 (9.5)

−0.144

−0.003

pTis

1 (0.2)

0 (0.0)

pT1

26 (7.5)

20 (5.4)

pT2

85 (24.7)

95 (25.9)

pT3

179 (52.0)

179 (48.9)

pT4

13 (3.7)

37 (10.1)

Pathological N-stage

pN0

251 (72.9)

243 (66.3)

−0.144

−0.003

pN1

57 (16.5)

76 (20.7)

pN2

33 (9.5)

47 (12.8)

Variable

Surgical approach

Standardised differences

TaTME, No. (%)

LapTME, No. (%)

Before IPTW

After IPTW

pN3

0 (0.0)

0 (0.0)

  

pN1c

3 (0.8)

0 (0.0)

Sphincter saving surgeryb

334 (97.0)

272 (74.3)

NA

NA

  1. Abbreviations: TaTME, transanal total mesorectal excision; LapTME, laparoscopic total mesorectal excision; IPTW, inverse probability of treatment weighting; AMC, Amsterdam University Medical Centers; ASA, American Society of Anesthesiologists; BMI, body mass index; AV, anal verge; CRM, circumferential resection margin; NAT, neoadjuvant therapy; TRG, tumour regression grade; NA, not applicable
  2. a Including only patients treated with NAT. The TRG system developed by Ryan et al. was used17
  3. b Not included in the IPTW calculation due to the large differences between groups. It was used as an adjustment cofactor in Cox models